---
pmcid: PMC10025226
image_filename: 262_2022_3283_Fig5_HTML.jpg
article_title: A Phase I-II multicenter trial with Avelumab plus autologous dendritic
  cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal
  cancer patients; GEMCAD 1602 study.
citation: Marta Espa√±ol-Rego, et al. Cancer Immunol Immunother. 2023;72(4):827-840.

doi: 10.1007/s00262-022-03283-5
journal_title: Cancer Immunology, Immunotherapy
journal_nlm_ta: Cancer Immunol Immunother
publisher_name: Springer Berlin Heidelberg

keywords:
- Vaccines
- Metabolism
- Resistance

---
